About PTC

PTC THERAPEUTICS ANNOUNCES ADDITIONAL STUDY

OF ATALUREN IN PATIENTS WITH ADVANCED NONSENSE MUTATION DUCHENNE/BECKER MUSCULAR DYSTROPHY...

 

Details